January 24, 2017
Webinar
This first webcast of our series will explore both the economic market factors of the biosimilar world and patent strategies, and how they impact target selection for biologics and biosimilars. In contrast to the development of generic small molecules, it has been reported that it takes seven to eight years to develop a biosimilar at a cost of between $100 million and $250 million. The identification of targets requires detailed analyses of the marketplace, patent portfolios, long-term strategies for optimizing and navigating patent portfolios, and technical and regulatory issues in developing a biologic or biosimilar.
The panel will discuss factors for consideration in strategic selection and protection of biologic products, including:
This webinar is the first in Finnegan’s 2017 “Biologics and Biosimilars: The Big Picture.”
Moderator:
Basil “Bill” J. Lewris
Speakers:
Leslie A. McDonell
Linda A. Wadler
Tuesday, January 24, 2017
10:00 - 11:00 a.m. PST
1:00 - 2:00 p.m. EST
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.